Journal of Urology最新文献

筛选
英文 中文
Infection and Inflammation of the Genitourinary Tract. 泌尿生殖道感染与炎症。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-29 DOI: 10.1097/JU.0000000000004424
J Quentin Clemens
{"title":"Infection and Inflammation of the Genitourinary Tract.","authors":"J Quentin Clemens","doi":"10.1097/JU.0000000000004424","DOIUrl":"10.1097/JU.0000000000004424","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"668-669"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143059265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uro-Science. Uro-Science。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2024-12-20 DOI: 10.1097/JU.0000000000004366
Anthony Atala
{"title":"Uro-Science.","authors":"Anthony Atala","doi":"10.1097/JU.0000000000004366","DOIUrl":"10.1097/JU.0000000000004366","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"665-666"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142864756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/JU.0000000000004467
Benjamin Borgert, Mary E Westerman
{"title":"Editorial Comment.","authors":"Benjamin Borgert, Mary E Westerman","doi":"10.1097/JU.0000000000004467","DOIUrl":"10.1097/JU.0000000000004467","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"567"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-06 DOI: 10.1097/JU.0000000000004449
Niels V Johnsen
{"title":"Editorial Comment.","authors":"Niels V Johnsen","doi":"10.1097/JU.0000000000004449","DOIUrl":"10.1097/JU.0000000000004449","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"635-636"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer Trial. 人工智能数字病理算法预测根治性前列腺切除术后PLCO试验的生存率。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-22 DOI: 10.1097/JU.0000000000004435
Eric V Li, Yi Ren, Jacqueline Griffin, Jialin Han, Rikiya Yamashita, Akinori Mitani, Ruoji Zhou, Huei-Chung Huang, Ximing Yang, Felix Y Feng, Andre Esteva, Hiten D Patel, Edward M Schaeffer, Lee A D Cooper, Ashley E Ross
{"title":"An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer Trial.","authors":"Eric V Li, Yi Ren, Jacqueline Griffin, Jialin Han, Rikiya Yamashita, Akinori Mitani, Ruoji Zhou, Huei-Chung Huang, Ximing Yang, Felix Y Feng, Andre Esteva, Hiten D Patel, Edward M Schaeffer, Lee A D Cooper, Ashley E Ross","doi":"10.1097/JU.0000000000004435","DOIUrl":"10.1097/JU.0000000000004435","url":null,"abstract":"<p><strong>Purpose: </strong>Clinical variables alone have limited ability to determine which patients will have recurrence after radical prostatectomy (RP). We evaluated the ability of locked multimodal artificial intelligence (MMAI) algorithms trained on prostate biopsy specimens to predict prostate cancer-specific mortality (PCSM) and overall survival (OS) among patients undergoing RP with digitized RP specimens.</p><p><strong>Materials and methods: </strong>The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Randomized Controlled Trial randomized subjects from 1993 to 2001 to cancer screening or control. A subset of patients who underwent RP with available digitized histopathological images and subsequent survival data were identified. Distant metastasis (DM) and PCSM MMAIs originally trained on biopsy slides for patients undergoing radiation were evaluated for prediction of PCSM and OS. Cox proportional hazards modeling and Kaplan-Meier survival curve analysis were used.</p><p><strong>Results: </strong>In total, 1032 patients who underwent RP with median follow-up of 17 years (IQR, 14.3, 19.3 years) were identified. MMAI algorithms for PCSM and DM both predicted PCSM (HR, 2.31, 95% CI, 1.6-3.35, <i>P</i> < .001 and HR, 1.96, 95% CI, 1.35-2.85, <i>P</i> < .001, respectively). Similarly, DM and PCSM MMAI predicted OS (HR, 1.22, 95% CI, 1.01-1.47, <i>P</i> = .04 and HR, 1.19, 95% CI, 1.02-1.4, <i>P</i> = .03).</p><p><strong>Conclusions: </strong>Locked MMAI algorithms previously developed and validated on biopsy specimens from patients undergoing radiation for prostate cancer successfully predicted clinical outcomes when applied to RP specimens from patients treated with surgery. MMAI models and other biomarkers may help select patients who may benefit from postoperative treatment intensification with androgen deprivation therapy or radiation.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"600-608"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology. 泌尿肿瘤学:膀胱、阴茎、尿道癌及肿瘤学基本原理。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2024-12-11 DOI: 10.1097/JU.0000000000004349
Sam S Chang
{"title":"Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.","authors":"Sam S Chang","doi":"10.1097/JU.0000000000004349","DOIUrl":"10.1097/JU.0000000000004349","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"666-668"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Contemporary Estimate of Vasectomy Failure in the United States: Analysis of US Claims Data. 美国输精管切除术失败的当代估计:美国索赔数据分析。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2024-12-31 DOI: 10.1097/JU.0000000000004405
Albert Ha, Chiyuan Amy Zhang, Shufeng Li, Ashkan Pourabhari Langroudi, Satvir Basran, Michael Scott, Frank Glover, Francesco Del Giudice, Michael L Eisenberg
{"title":"A Contemporary Estimate of Vasectomy Failure in the United States: Analysis of US Claims Data.","authors":"Albert Ha, Chiyuan Amy Zhang, Shufeng Li, Ashkan Pourabhari Langroudi, Satvir Basran, Michael Scott, Frank Glover, Francesco Del Giudice, Michael L Eisenberg","doi":"10.1097/JU.0000000000004405","DOIUrl":"10.1097/JU.0000000000004405","url":null,"abstract":"<p><strong>Purpose: </strong>We characterize trends in vasectomy utilization, delivery, and failure in a large administrative database.</p><p><strong>Materials and methods: </strong>We used the Merative MarketScan (2007-2021) Commercial Database to identify vasectomized men. Vasectomy failure (VF) was defined as documented pregnancy ≥ 6 months post procedure. Additional outcomes include the need for repeat vasectomy within 1 year and birth rates. Logistic and Cox proportional hazard regression were used to analyze factors associated with failure.</p><p><strong>Results: </strong>In a cohort of 489,277 vasectomized men, the mean (SD) age was 38 (6) years, with most of the procedures performed by urologists (n = 344,319). Overall postvasectomy pregnancy rate 6 months post procedure was 1.97 cases per 1000 persons per year, representing a pregnancy rate of 0.58%. Annual declines-particularly in recent years-in postvasectomy pregnancy (p<sub>trend</sub> = 0.03) and birth (p<sub>trend</sub> = 0.04) rates were observed. Older age and recent vasectomy years were associated with reduced odds of VF, while the absence of a postvasectomy semen analysis was associated with increased VF (adjusted odds ratio [aOR]: 1.14; 95% CI: 1.03-1.25; <i>P</i> < .001). Importantly, vasectomies performed by nonurologists (aOR: 1.56; 95% CI: 1.40-1.74; <i>P</i> < .0001) and vasectomies occurring in office-based settings (aOR: 1.25; 95% CI: 1.08-1.44; <i>P</i> < .01) were associated with higher odds of repeat procedures.</p><p><strong>Conclusions: </strong>VF is a rare phenomenon. Older age and vasectomies performed in later years correlate with decreased odds of failure, whereas the lack of postvasectomy semen analysis increases odds of failure. A higher pregnancy rate shortly after the procedure underscores the need to improve patient counseling.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"638-647"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer. 回复:临床报告的针对前列腺癌患者普遍生殖系基因检测的管理建议。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-10 DOI: 10.1097/JU.0000000000004439
Neal Shore
{"title":"Reply: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.","authors":"Neal Shore","doi":"10.1097/JU.0000000000004439","DOIUrl":"10.1097/JU.0000000000004439","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"649-650"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply by Authors. 作者回复。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-02-14 DOI: 10.1097/JU.0000000000004469
I Rivero Belenchón, C B Congregado Ruíz, G Gómez Ciriza, V Gómez Dos Santos, F J Burgos Revilla, R A Medina López
{"title":"Reply by Authors.","authors":"I Rivero Belenchón, C B Congregado Ruíz, G Gómez Ciriza, V Gómez Dos Santos, F J Burgos Revilla, R A Medina López","doi":"10.1097/JU.0000000000004469","DOIUrl":"10.1097/JU.0000000000004469","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"579"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial. 在一个种族和民族多样化的队列中,比较Stockholm3、血清生物标志物和风险计算器来预测前列腺癌:对Stockholm3多民族SEPTA试验的评价。
IF 5.9 2区 医学
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-04-09 DOI: 10.1097/JU.0000000000004437
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, Martin Eklund, Andrea Discacciati, Tobias Nordström, Rebecca A Hubbard, Nathan Perlis, Michael R Abern, Daniel M Moreira, Paul Yonover, Alexander K Chow, Kara Watts, Michael A Liss, Gregory R Thoreson, Andre L Abreu, Geoffrey A Sonn, Anna Plym, Fredrik Wiklund, Henrik Grönberg, Adam B Murphy, Scott Eggener
{"title":"A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial.","authors":"Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, Martin Eklund, Andrea Discacciati, Tobias Nordström, Rebecca A Hubbard, Nathan Perlis, Michael R Abern, Daniel M Moreira, Paul Yonover, Alexander K Chow, Kara Watts, Michael A Liss, Gregory R Thoreson, Andre L Abreu, Geoffrey A Sonn, Anna Plym, Fredrik Wiklund, Henrik Grönberg, Adam B Murphy, Scott Eggener","doi":"10.1097/JU.0000000000004437","DOIUrl":"10.1097/JU.0000000000004437","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare performance of Stockholm3 in an external validation with commonly used prostate cancer biomarkers and risk calculators.</p><p><strong>Materials and methods: </strong>SEPTA was a multicenter trial validating Stockholm3 in a racially/ethnically diverse population of men meeting local care guidelines for prostate biopsy (2019-2023). In total, 2115 (98%) men with complete data for risk calculators and biomarkers were included. The primary outcome was detection of Grade Group ≥ 2 (GG ≥ 2) cancer. Predictors included Stockholm3, free/total PSA ratio, PSA density, European Randomized Study of Screening for Prostate Cancer-4, Prostate Biopsy Collaborative Group, and Prostate Cancer Prevention Trial version 2 risk calculators. Performance characteristics were computed at clinically used thresholds for each risk score. ROC analysis, graphical calibration assessment, and decision curve analysis were performed.</p><p><strong>Results: </strong>Among 2115 men, median age was 63 years (IQR: 58-68), median PSA was 6.1 ng/mL (IQR: 4.5-9.0), 415 (20%) had a prior negative prostate biopsy, and 356 (17%) had an MRI performed before biopsy. There were 1200 (56.7%) benign biopsies performed, 307 (14.5%) GG1 cancers detected, and 608 (28.8%) GG ≥ 2 cancers detected. The Stockholm3 test had superior discrimination (all <i>P</i> < .001) compared with all evaluated biomarkers and risk calculators with an AUC of 0.82 vs 0.72 for free/total PSA, 0.76 for PSA density, 0.77 for European Randomized Study of Screening for Prostate Cancer-4, 0.74 for Prostate Biopsy Collaborative Group, and 0.78 for Prostate Cancer Prevention Trial version 2. Decision curve analysis demonstrated superior performance of Stockholm3, showing the highest positive net benefit. Compared with free/total PSA, Stockholm3 could reduce unnecessary biopsies by 44% while maintaining a 0.95 sensitivity.</p><p><strong>Conclusions: </strong>Stockholm3 outperforms other commonly used biomarkers and risk calculators for detecting GG ≥ 2 cancer in a diverse population.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":"213 5","pages":"590-599"},"PeriodicalIF":5.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143811604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信